Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
Clinical and Experimental Rheumatology|February 25, 2011
Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practiceRobert J Moots, Boulos Haraoui, Marco Matucci-Cerinic, et al.Lancet (London, England)|November 20, 2016
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE studyJosef S Smolen, Gerd-Rüdiger Burmester, Bernard Combe, et al.ACR Open Rheumatology|June 27, 2024
Identification of Gaps in Quality of Care and Good Practice Interventions in Rheumatoid Arthritis: Insights From a Literature Review and Qualitative Study of Nine Centers in North AmericaJeffrey R Curtis, Vivian P Bykerk, Mary K Crow, et al.RMD Open|October 29, 2015
Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian populationBoulos Haraoui, Algis Jovaisas, William G Bensen, et al.Annals of the Rheumatic Diseases|January 7, 2015
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysisCamille Roubille, Vincent Richer, Tara Starnino, et al.Annals of the Rheumatic Diseases|January 1, 2015
Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosisRene Westhovens, Manuel Robles, Antonio Carlos Ximenes, et al.The Journal of Rheumatology|July 17, 2015
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity InitiativeCamille Roubille, Vincent Richer, Tara Starnino, et al.Journal of Cutaneous Medicine and Surgery|November 23, 2018
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim A Papp, Boulos Haraoui, Deepali Kumar, et al.Journal of the Canadian Association of Gastroenterology|October 17, 2019
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.Rheumatology International|January 8, 2013
Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trialsAmanda J Steiman, Janet E Pope, Heather Thiessen-Philbrook, et al.Pageof 14